by NDASA | Oct 12, 2023 | Drug & Alcohol Testing, Resources
The Department of Health and Human Services (HHS) has revised its Oral Fluid Mandatory Guidelines (effective October 10, 2023) and its Urine Mandatory Guidelines (effective February 1, 2024). HHS published the following Notice in the October 12, 2023 Federal Register:...
by Guest Contributer | Sep 11, 2023 | Drug & Alcohol Testing, Feature, Marijuana & CBD, Newsletter Only, Workplace Safety
|by Bill Current This article was written by Bill Current of the Current Consulting Group (CCG) on behalf of Premier Biotech for publication by NDASA. For further information about the subjects covered in this article, please email Bill...
by NDASA | Feb 24, 2022 | Advocacy, Drug & Alcohol Testing, Drug Legislation, Feature
From a Member’s Memo podcast with NDASA Executive Director Jo McGuire.* From time to time, we receive calls from members questioning the National Drug and Alcohol Screening Association’s work in our nation’s capital and why our organization would need a...
by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, For Employers and Workplace Safety & Wellness Professionals, Resources
Quest Diagnostics works to empower people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, Quest’s diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and...
by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, For Employers and Workplace Safety & Wellness Professionals, Resources, Uncategorized
The U.S. Department of Health and Human Services is proposing to establish scientific and technical guidelines for the inclusion of hair specimens in the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Guidelines). We encourage you to review the...
by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, Resources
Guidance for Transgender Collections Under Direct Supervision (Podcast) by NDASA | The U.S. Department of Health and Human Services has addressed this issue for USCG collections, but federal Department of Transportation has not. What should you do? NDASA has...
by NDASA | Apr 22, 2021 | For Drug Testing Industry Professionals, Resources
The Federal Drug Testing Custody and Control Form is the document used for drug test ordering, specimen collection processing, and chain of custody documentation for workplace drug testing. Get a look at the 2020 form, the most recent version of the form available,...
by NDASA | Jul 3, 2020 | Feature, Marijuana & CBD
Is CBD medicine or isn’t it? Is it safe? Can it impact a drug test result? Cannabis has been the focus of considerable debate, advocacy, and policy, generating both interest and misinformation. There is a great deal of uncertainty about cannabis and cannabinoid...
by NDASA | Apr 16, 2020 | DOT, Feature
In recent weeks, the National Drug & Alcohol Screening Association (NDASA) has hosted a series of COVID-19 Townhall Discussions for its members in the drug and alcohol screening industry. The main takeaways from these meetings? Our members are passionate...
by NDASA | Mar 15, 2020 | Feature, FMCSA
Since the launching of the new Federal Motor Carrier Safety Administration Drug and Alcohol Clearinghouse in January 2020 many questions have arisen about Clearinghouse processes and procedures. Everyone is committed to making the database work well for all...
